Prevalence of Wild Type ATTR

CompletedOBSERVATIONAL
Enrollment

94

Participants

Timeline

Start Date

November 1, 2019

Primary Completion Date

October 31, 2021

Study Completion Date

October 31, 2022

Conditions
Wild-type Transthyretin Amyloidosis
Interventions
DIAGNOSTIC_TEST

HE and Congo red staining

Biopsies will be formalin fixed, processed routinely, and sent to the Department of Pathology for evaluation by hematoxylin and eosin and Congo red staining by pathologists. Biopsy specimens with confirmed amyloid deposits via Congo red staining will be further analyzed using immunohistochemistry for subtyping.

Trial Locations (1)

6500

Oncology Institute of Southern Switzerland, Bellinzona

All Listed Sponsors
collaborator

University of Kiel

OTHER

collaborator

Ente Ospedaliero Cantonale, Bellinzona

OTHER

lead

Oncology Institute of Southern Switzerland

OTHER

NCT03966105 - Prevalence of Wild Type ATTR | Biotech Hunter | Biotech Hunter